SF3B1 and myelodysplastic syndrome: Then, we propose that disruption of mitochondrial complex III mediated by mutant SF3B1 could be dependent on the cellular context, and the metabolic consequences of SF3B1 mutations in CD34+ of MDS patients still of major importance.